Asher Bio

About Asher Bio

Asher Biotherapeutics is pioneering a new approach with cis-targeted immunotherapies that selectively activate specific immune cell types to drive desired therapeutic responses. Their mission focuses on addressing shortcomings of conventional immunotherapies, optimizing efficacy, and minimizing side effects, with a strong emphasis on making a significant impact for patients.

Products & Services

Etakafusp Alfa (formerly AB248):A cis-targeted IL-2 therapy that specifically activates CD8+ effector T cells, showing promising anti-tumor activity and a well-tolerated safety profile in ongoing Phase 1a/1b clinical trials.

AB821:A product in the pipeline, specifics not detailed in the content.

Cis-targeted Cytokine Augmentation of Cell Therapies:A therapy approach in the pipeline aimed at enhancing cell therapies through cis-targeting, specifics not detailed.

Specialties

Cis-targeted Immunotherapies Selective Immune Cell Activation IL-2 Mediation

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Series C T: - FT: Series C	A: 55000000 MR: - FA: 55 million FAN: 55000000	D: 2024-04-16 FD: 2024-04-16	7 investors

Series C Latest

2024-04-16

$55.0M

7 investors (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

I

Ivana Djuretic

Founder, Chief Executive Officer

K

Kyle Elrod

Chief Operating Officer

A

Andy Yeung

Founder, Chief Technology Officer

D

Don O'Sullivan

Chief Business Officer

P

Priti Patel

Consultant CMO

J

Julie Trulson

Vice President, Head of CMC

View 16 more team members with Pro

Unlock Full Team Directory

Recent News

Asher Bio Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised